Acrivon Therapeutics, Inc. (ACRV)
2.09
+0.03
(+1.46%)
USD |
NASDAQ |
Aug 31, 16:00
2.05
-0.04
(-1.91%)
After-Hours: 20:00
Acrivon Therapeutics Total Liabilities (Quarterly) : 12.43M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.43M |
| March 31, 2026 | 12.32M |
| December 31, 2025 | 18.30M |
| September 30, 2025 | 16.70M |
| June 30, 2025 | 15.55M |
| March 31, 2025 | 15.96M |
| December 31, 2024 | 19.80M |
| September 30, 2024 | 17.79M |
| June 30, 2024 | 14.53M |
| March 31, 2024 | 12.54M |
| Date | Value |
|---|---|
| December 31, 2023 | 17.07M |
| September 30, 2023 | 12.94M |
| June 30, 2023 | 10.86M |
| March 31, 2023 | 9.728M |
| December 31, 2022 | 10.75M |
| September 30, 2022 | 10.81M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 130.40M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 99.09M |
| Shareholders Equity (Quarterly) | 86.66M |
| Debt to Equity Ratio | 0.0244 |
| Current Ratio | 7.993 |
| Net Debt Paydown Yield | 0.37% |